Stephen F. Flatt - Mar 5, 2024 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen F. Flatt
Stock symbol
NHC
Transactions as of
Mar 5, 2024
Transactions value $
$0
Form type
4
Date filed
3/7/2024, 05:03 PM
Previous filing
Feb 26, 2024
Next filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Award $0 +2.78K +4.9% $0.00 59.5K Mar 5, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Award $0 +15K $0.00 15K Mar 5, 2024 Common Stock 15K $94.10 Direct F2, F3
holding NHC Option to Purchase Common Stock 4.73K Mar 5, 2024 Common Stock 4.73K $63.96 Direct
holding NHC Option to Purchase Common Stock 15K Mar 5, 2024 Common Stock 15K $53.94 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2025, the next 33 1/3% vesting on 1/1/2026, and the final 33 1/3% vesting on 1/1/2027.
F2 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F3 These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 5, 2025; one-third (1/3) will vest on March 5, 2026; and the final one-third (1/3) will vest on March 5, 2027.